is a keystone microorganism present in more than 95% of all BV cases. The first step of the infection process in BV is mediated by interaction of microorganisms with epithelial cells (ecs). However, the role of these cells in BV pathogenesis is largely unknown. the present study aimed to investigate the vaginal ec response during BV. twenty healthy women and 34 women with BV were enrolled in this study. The number of ECs in the vaginal swab was counted and analyzed for intracellular signals and apoptosis by flow cytometry. Cell damage was evaluated by lactate dehydrogenase assay. compared to that in healthy donors, the percentage of exfoliated vaginal ecs was increased in women with BV, and an absence of neutrophils was observed in both groups. Activation signals, such as p-iκBα and c-fos were unmodulated in the vaginal ecs of women with BV. Moreover, EC damage and apoptosis were significantly increased in patients with BV. Apoptosis was related to caspase-3 activation and the presence of G. vaginalis. This study provides the first evidence of a direct involvement of G. vaginalis in the apoptotic process of vaginal ECs during BV. This effect was mediated by caspase-3 activation, and G. vaginalis appeared to be one of causes for inducing ec apoptosis in BV. Hence, our findings suggest a possible explanation for the increased exfoliation of ECs in the vagina during BV.
Results
It has been previously reported that BV is characterized by decreased abundance of Lactobacillus spp. and increased abundance of anaerobic bacteria, particularly G. vaginalis 3 . First, we identified G. vaginalis isolates by MALDI-TOF MS analysis. Next, we determined the presence of Lactobacillus spp., as well as, the number of ECs in our clinical samples. As shown in Fig. 1 , we observed the presence of G. vaginalis and complete absence of lactobacilli in BV specimens. Conversely, healthy donor samples showed a very low number or the absence of G. vaginalis cells and a microbiota dominated by lactobacilli. Furthermore, the complete absence of neutrophils was reported in both groups (Fig. 1) .
In subsequent experiments, we evaluated the amount of EC exfoliation in clinical samples from women with BV. As shown in Fig. 2a , the number of exfoliated ECs increased in the vaginal environment during BV relative to that in healthy donors. It has been reported that the vaginal pH increases during vaginal infections and assessment of vaginal pH may be useful in evaluating vaginal health 11 . Determination of the pH level of our clinical samples showed a pH < 4.5 (4.0 ± 0.0) in healthy women, while a pH, consistently, > 4.5 (5.16 ± 0.06) in patients with BV. In addition we observed a significant correlation between the number of exfoliated ECs and pH values of our specimens (Fig. 2b) .
Previous in vitro studies have shown enhanced inflammatory response and tissue damage by G. vaginalis 5, 8 . Indeed, activation of vaginal ECs may occur via the c-Fos/p38 signaling pathway during vaginal candidiasis 10, 12 ; however, the contribution of these signaling molecules in the downstream molecular cascade in vaginal ECs during bacterial infections remains unknown. Evaluation of c-Fos levels in the vaginal ECs from patients with BV and healthy donors, no difference in levels was observed between the two groups ( Fig. 2c) .
Several transcription factors, including those related to the IκB kinase/NF-κB signaling pathway, are critically involved in inflammatory response against invading microorganisms 10, 13 . Therefore, we analyzed the activation of the NF-κB signaling pathway in vaginal ECs from 12 women with BV and 12 healthy donors. No differences in activation of NF-κB signals were detected between the two groups ( Fig. 2d ).
Previous reports indicate that G. vaginalis induces EC damage 5 ; therefore, we performed LDH assay to investigate this effect in our samples from healthy donors (n = 12) and patients with BV (n = 12). The results showed a consistent increase in the percentage of damaged vaginal ECs in samples from women with BV compared to those from healthy donors ( Fig. 3a ).
Next, we assessed LDH release, which may reflect apoptosis 14 , to determine the level of EC apoptosis in clinical samples from women with BV (n = 20) and healthy donors (n = 14). As shown in Fig. 3b , a significant increase in the percentage of apoptotic ECs was detected in samples from patients with BV (43.86% ± 4.53%) compared to those from healthy women.
Caspase-3 is a crucial mediator of apoptosis in both extrinsic (dead ligand) and intrinsic (mitochondrial) pathways 15 ; therefore, we evaluated the contribution of caspase-3 in the apoptotic process. As shown in Fig. 3c , consistent activation of caspase-3 was observed in vaginal ECs from women with BV, whereas caspase-3 was very poorly expressed or absent in ECs from healthy donors. A significant correlation between the percentage of LDH release and the percentage of vaginal ECs undergoing apoptosis or the percentage of caspase-3-positive cells was observed in BV and healthy subjects. Furthermore, a positive correlation between caspase-3 levels and EC apoptosis was also observed ( Fig. 3d) .
To determine the relationship between EC apoptosis and the presence of G. vaginalis cells, we performed ex vivo experiments using the vaginal ECs of selected healthy subjects that were treated with G. vaginalis clinical isolates from three women enrolled in this study. Given that BV can be considered a biofilm infection primarily consisting of G. vaginalis 16 , we evaluated the biofilm-forming ability of the three G. vaginalis clinical isolates (designated GV 1, GV 2, and GV 3) under our experimental conditions. To this end, the strains (10 8 CFU/ml) were incubated for 48 h and biofilm formation on an abiotic surface (polystyrene plates) was analyzed by CV staining, as described in the Methods section. As shown in Fig. 4a , GV 3 strain exhibited the highest biofilm-forming ability. In subsequent experiments, the ability of strains GV 1, GV 2, and GV 3 to induce vaginal EC apoptosis in healthy subjects was evaluated. As shown in Fig. 4b , GV 3 induced vaginal EC apoptosis at all concentrations tested, while GV 1 and GV 2 were able to induce apoptosis of vaginal ECs only at the highest concentration.
Discussion
BV is one of the most common pathological conditions among women of childbearing age. Vaginal dysbiosis and BV usually occur when Lactobacillus spp., which is the predominant species in the vagina of healthy women, is replaced by various anaerobic bacteria, particularly G. vaginalis. Despite the relevance of this infection and its impact on public health, BV remains an ambiguous condition.
In this study, we demonstrated the dysregulation of a series of parameters in samples from women with BV. Our results showed: 1) a consistent increase in pH level, 2) an increased number of exfoliated ECs, 3) a lack of certain inflammatory signals, 4) increased vaginal EC damage, and 5) increased vaginal EC apoptosis via caspase-3 activation. Finally, even though we cannot exclude the involvement of other bacteria, our data demonstrate that G. vaginalis plays an important role in inducing apoptosis of vaginal ECs.
Compelling evidence shows that Lactobacillus spp. produce lactic acid and peroxide hydrogen, which contribute to a hostile environment for the growth of harmful organisms 17 . BV implies a modification of the vaginal microbiota, with increased colonization of several anaerobic or facultative microorganisms and a consequent increase in the pH level 18 . Compared to the samples from healthy subjects, in the BV samples, we observed an increase in pH value, as well as, an augmentation of ECs exfoliation. This was due to an increase in the population of anaerobic bacteria in the vagina and, particularly, to the presence of G. vaginalis. Hence, it can be speculated that the production of vaginolysin (VGL), which is the most important virulence factor of G. vaginalis, is responsible for the enhanced exfoliation 19 . Although we were unable to assess the VGL levels of the strains in our study, previous studies have suggested that higher VGL concentrations are related to BV with rare lactobacilli in the vaginal microbiota 20 , a condition that was also manifested in our clinical samples. Furthermore, we identified a positive relationship between increased pH and augmented exfoliation.
ECs are in constant contact with various microbes and respond to pathogenic organisms. This condition elicits an appropriate immune response via activation of cellular signalling pathways, such as c-Fos and NF-κB, similar to that induced by fungal infections 10 . In our samples, we did not observe the activation of selected inflammatory signaling molecules in vaginal ECs. However, we cannot exclude that, during BV, there is activation of alternative intracellular signals that leads to production of inflammatory cytokines. To our knowledge, this is the first study to demonstrate that vaginal ECs are unresponsive to microorganisms during BV. Furthermore, we also demonstrated that, consistent vaginal ECs damage was manifested. Indeed, previously published data were obtained exclusively from in vitro experimental models using epithelial cell lines 5, 21 .
In this study, we provide evidence of vaginal EC apoptosis during BV via a process that involves caspase-3 activation. Given that vaginal ECs are strongly involved in BV as clue cells, it is likely that the enhanced apoptosis represents host response, which removes the infected and exhausted cells. The absence of NF-κB activation correlates with the increased apoptosis observed in ECs from the intestinal region 22, 23 . Our findings, also, reveal that the presence of G. vaginalis is strictly associated with apoptosis induction, although we cannot exclude the possible contribution of other factors and microorganisms to this phenomenon.
Apoptosis in response to invading pathogens may represent a host defense mechanism for the elimination of infected cells and/or a strategy by which microorganisms disturb the EC barrier against invasion of deeper mucosal layers required for prolonged bacterial colonization. In this study, we provide evidence that G. vaginalis induces apoptosis of vaginal ECs, although the underlying mechanism remains unknown. In addition, the presence of other microorganisms in the vaginal environment should be considered in future studies. The optical density (OD) was measured at 590 nm using a 96-well microplates reader. Data represent the mean ± SEM of duplicate samples from three different experiments. The statistical significance of differences between the groups was determined by ANOVA + Bonferroni as a post-hoc comparison. *P = 0.0111 GV 3 vs. GV 1; # P = 0.0077 GV 3 vs. GV 2; P > 0.9999 GV 1 vs. GV 2 (a). Vaginal ECs from healthy donors (n = 9) were washed three times, counted, adjusted to 2×10 5 /ml in RPMI 1640 supplemented with 10% FCS. Cells were then cultured for 18 h at 37 °C under 5% CO 2 in 96-well microtiter plates (100 µl/well) with or without cycloheximide (CHX) 100 μg/ml, GV 1, GV 2 and GV 3 at 2×10 5 /ml, 100 µl/well (1:1) or GV 1, GV 2 and GV 3 at 2×10 6 /ml, 100 µl/well (10:1). Immediately (t = 0) and after incubation, ECs were centrifuged, suspended in hypotonic propidium iodide solution and kept for 1 h in the dark at room temperature. Data are expressed as the percentage of vaginal ECs undergoing apoptosis. Data represent the mean ± SEM of duplicate samples from 9 different women for GV3 and 5 different women for GV 1 and GV 2. The statistical significance of differences between the groups was determined by Kruskal-Wallis + Dunn's as a post-hoc comparison. *P = 0.0025 CHX vs. ECs from healthy donors (t = 18 h); *P = 0.0119 GV 1 (10:1) vs. ECs from healthy donors (t = 18 h); *P = 0.0175 GV 2 (10:1) vs. ECs from healthy donors (t = 18 h); *P = 0.0012 GV 3 (1:1) vs. ECs from healthy donors (t = 18 h); *P = 0.0002 GV 3 (10:1) vs. ECs from healthy donors (t = 18 h); P > 0.9999 ECs from healthy donors (t = 0) vs. ECs from healthy donors (t = 18 h); P = 0.1779 GV 1 (1:1) vs. ECs from healthy donors (t = 18 h); P = 0.1692 GV 2 (1:1) vs. ECs from healthy donors (t = 18 h) (b).
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Methods

participants.
A total of 54 Caucasian, non-pregnant, non-menopausal, and non-diabetic women (aged 19-50 years) attending the microbiological diagnostic service at the University Hospital Santa Maria della Misericordia, Perugia (Italy) from November 2018 to July 2019 were randomly enrolled in this study. The exclusion criteria were: patients outside the age range of 19-50 years, patients with a history of tubal ligation or hysterectomy, and women with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Streptococcus agalactiae, Saccharomyces cerevisiae, Candida spp., or HIV infections 19 . Individuals were excluded from the study if they had received systemic or local antibiotic/antimicrobial therapy within the previous 2 months, were menstruating at the time of examination, were using an intrauterine contraceptive device, or had a history of sexually transmitted diseases 1 . The subjects enrolled in this study were divided into two groups: 34 women with BV and 20 healthy women (Fig. 1a ). Diagnosis of BV was based on Amsel's and Nugent's criteria 1, 8, 19, 26 . Prior to enrollment, all patients completed a questionnaire indicating their health status and symptoms of vaginal disease. All participants provided written informed consent in accordance with the Declaration of Helsinki. Local Ethical Committee CEAS (Comitato Etico delle Aziende Sanitarie, Umbria, Italy) approval was received for the entire study (MICROCA). All methods were performed in accordance with the relevant guidelines and regulations.
Sample collection. Three vaginal swabs were collected from each woman enrolled in this study. One swab was used for pH measurement using pH-Fix strips (Macherey-Nagel GmbH & Co. KG, Düren, Germany).
One swab was soaked in 1 ml of saline. A certain volume of this sample was cultured on BD Columbia CNA Agar containing 5% Sheep Blood (Becton Dickinson, New Jersey, USA). For G. vaginalis identification, mass-spectrometry (MALDI-TOF MS) analysis (Bruker Daltonik GmbH, Bremen, Germany) was performed. The remaining volume of the sample was used for Gram stain (Nugent's criteria) for the diagnosis of BV. The last swab was soaked in 1 ml of saline and vortexed for at least one minute. Around 100 μL of the sample was examined under a light microscope (Olympus, Milan, Italy) to evaluate the presence of neutrophils (PMNs) and EC exfoliation. The numbers of PMNs and ECs were counted in four fields at ×400 magnification and expressed as the average number of PMNs or ECs/field, as previously described 10, 19, 27 .
The remaining sample (900 μl) was centrifuged at 1,600 rpm for 10 min, and the cellular fraction was used for flow cytometric analysis or for assessment of EC damage or EC apoptosis.
Due to the limited amount of ECs in our samples, we were unable to perform all analyses for all samples. In each figure, we have reported the number of BV and healthy specimens used.
MALDi-tof MS. For MALDI-TOF MS, bacteria were grown in the swab culture, as described above, and bacterial extracts were prepared as described previously 28, 29 . Briefly, cells from a single colony of fresh vaginal sample culture were used to prepare samples according to the microorganism profiling ethanol/acid formic extraction procedure, as per the manufacturer's instructions. After centrifugation at maximum speed for 2 min, 1 μl of the supernatant containing the bacterial extract was allowed to dry after overlaying it with 2 μl of a chemical matrix (saturated solution of α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile/2.5% trifluoroacetic acid) on a polished steel MALDI target plate. The samples were then processed using the microflex LT mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) equipped with a 20-Hz nitrogen laser. The spectra were recorded in the positive linear mode as described previously 30 . flow cytometric analysis. The total cellular fractions obtained from selected vaginal swabs were fixed in 1.5% formalin for 5 min at room temperature, washed, and analyzed by flow cytometry (FACSCalibur, BD Biosciences, New Jersey, USA) to determine FSC/SSC vaginal EC parameter, as previously reported 10, 31 , or incubated for 20 min at room temperature in the dark with a FITC-conjugated mouse monoclonal antibody to human epithelial cell adhesion molecule (EpCAM, CD326) (IgG2 ak ) (0.5 µg/test; eBioscience, Thermo Fisher Scientific, California, USA), or permeabilized with absolute methanol (500 µl/10 6 cells) for 10 min on ice and then incubated with a FITC-conjugated mouse monoclonal antibody to human p-IκBα (IgG 2bk ) or human c-Fos (IgG 1k ) (both dilution 1:50; Santa Cruz Biotechnology, California, USA) or PE-conjugated rabbit monoclonal antibody to human active caspase-3 (IgG) (5 μl/test, BD Pharmingen TM , Allschwil, Switzerland). After incubation, the cells were washed with Fluorescein Buffer and 10,000 events were analyzed by flow cytometry. More than 98% of the cells contained within the gate were EpCAM-positive. Isotype controls, including mouse IgG 2ak , IgG 2bk , and IgG 1k and rabbit IgG were purchased from Novus Biologicals (Colorado, USA). PE-conjugated sheep anti-mouse IgG (whole molecule) and FITC-conjugated mouse anti-rabbit IgG (whole molecule) were purchased from Sigma-Aldrich (Munich, Germany) and Santa Cruz Biotechnology (California, USA), respectively. Autofluorescence was assessed using untreated cells. Specific fluorescence was assessed by comparison with results from the specific mouse isotype control. The data were expressed as the percentage of positive cells. ec damage assay. The number of ECs in the selected vaginal samples was counted, adjusted to 1 × 10 6 / ml in phosphate-buffered saline (PBS), and cultured for 18 h at 37 °C under 5% CO 2 in 96-well microtiter plates (100 µl/well). Subsequently, EC damage was determined by the release of lactate dehydrogenase (LDH) into the surrounding medium using the Pierce LDH Cytotoxicity Detection kit (Thermo Fisher Scientific, California, USA). For each test, ECs from one healthy donor were used as the negative control (ECs cultured in PBS alone for spontaneous LDH activity) and positive control (ECs + lysis buffer in PBS for maximum LDH activity). LDH activity was measured spectrophotometrically at 492 nm. The percentage of damaged vaginal ECs was calculated
